NO167862C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt(1r, 5s, 6s)-2-substituert tio-6-((r)-1-hydroksyetyl)-1-metyl-carbapenem-3-karboksylsyrederivat. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktivt(1r, 5s, 6s)-2-substituert tio-6-((r)-1-hydroksyetyl)-1-metyl-carbapenem-3-karboksylsyrederivat.

Info

Publication number
NO167862C
NO167862C NO881534A NO881534A NO167862C NO 167862 C NO167862 C NO 167862C NO 881534 A NO881534 A NO 881534A NO 881534 A NO881534 A NO 881534A NO 167862 C NO167862 C NO 167862C
Authority
NO
Norway
Prior art keywords
carbapenem
hydroxyethyl
methyl
preparation
acid derivative
Prior art date
Application number
NO881534A
Other languages
English (en)
Other versions
NO167862B (no
NO881534L (no
NO881534D0 (no
Inventor
Toshio Kumagai
Hiroshi Matsunaga
Yoshisuke Machida
Yunosuke Nagase
Muneo Hikida
Yoshimitsu Nagao
Original Assignee
Lederle Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Japan Ltd filed Critical Lederle Japan Ltd
Publication of NO881534D0 publication Critical patent/NO881534D0/no
Publication of NO881534L publication Critical patent/NO881534L/no
Publication of NO167862B publication Critical patent/NO167862B/no
Publication of NO167862C publication Critical patent/NO167862C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO881534A 1987-04-11 1988-04-08 Analogifremgangsmaate for fremstilling av terapeutisk aktivt(1r, 5s, 6s)-2-substituert tio-6-((r)-1-hydroksyetyl)-1-metyl-carbapenem-3-karboksylsyrederivat. NO167862C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8901687 1987-04-11
JP63031033A JPS6425779A (en) 1987-04-11 1988-02-15 (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative

Publications (4)

Publication Number Publication Date
NO881534D0 NO881534D0 (no) 1988-04-08
NO881534L NO881534L (no) 1988-10-12
NO167862B NO167862B (no) 1991-09-09
NO167862C true NO167862C (no) 1991-12-18

Family

ID=26369486

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881534A NO167862C (no) 1987-04-11 1988-04-08 Analogifremgangsmaate for fremstilling av terapeutisk aktivt(1r, 5s, 6s)-2-substituert tio-6-((r)-1-hydroksyetyl)-1-metyl-carbapenem-3-karboksylsyrederivat.

Country Status (12)

Country Link
EP (1) EP0289801B1 (no)
JP (1) JPS6425779A (no)
KR (1) KR960002850B1 (no)
AU (1) AU613356B2 (no)
CA (1) CA1340274C (no)
DE (1) DE3860977D1 (no)
DK (1) DK168015B1 (no)
ES (1) ES2019674B3 (no)
FI (1) FI86729C (no)
GR (1) GR3001347T3 (no)
IL (1) IL85985A (no)
NO (1) NO167862C (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68916908T2 (de) * 1988-11-08 1994-12-01 Daiichi Seiyaku Co Carbapenemderivate.
US5102877A (en) * 1989-04-28 1992-04-07 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
JP2771637B2 (ja) * 1989-10-17 1998-07-02 シーアイ化成株式会社 作物栽培用被覆フイルム及びそれを用いる栽培方法
WO1991009860A1 (en) * 1989-12-28 1991-07-11 Banyu Pharmaceutical Co., Ltd. New carbapenem derivative
US5227376A (en) * 1990-02-14 1993-07-13 Sumitomo Pharmaceuticals Co., Ltd. β-lactam compounds and their production
US5241073A (en) * 1990-10-12 1993-08-31 Lederle (Japan) Process for preparing (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo [1,2-a][1,2,4]triazolium-6-yl)]thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate and starting materials thereof
ES2093010T3 (es) * 1990-10-12 1996-12-16 Lederle Japan Ltd Procedimiento para preparar (1r,5s,6s)-2-((6,7-dihidro-5h-pirazolo(1,2-a)(1,2,4)triazolio-6-il)tio)-6-((r)-1-hidroxietil)-1-metil-carbapenem-3-carboxilato y sus materiales de partida.
US5286721A (en) * 1990-10-15 1994-02-15 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
TW264475B (no) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
WO1993019072A1 (en) * 1992-03-17 1993-09-30 Yamanouchi Pharmaceutical Co., Ltd. Carbapenem derivative
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
JP2000508343A (ja) * 1996-10-28 2000-07-04 メルク エンド カンパニー インコーポレーテッド 安定化されたカルバペネム抗生物質組成物及びその製造方法
AU732335B2 (en) * 1997-09-09 2001-04-12 Merck & Co., Inc. 3-(iodophenoxymethyl) carbapenem antibacterials
KR100476672B1 (ko) * 2001-08-16 2005-03-17 한국과학기술연구원 티올 유도체 및 이를 치환기로 갖는 1-베타-메틸-카바페넴유도체
JP2008303143A (ja) * 2005-08-19 2008-12-18 Shionogi & Co Ltd 連続化反応によるカルバぺネム誘導体の製法
EP2014666A4 (en) * 2006-04-28 2011-06-01 Kaneka Corp IMPROVED PROCESS FOR CRYSTALLIZING INTERMEDIATES OF CARBAPENEMIC ANTIBIOTICS
CN103159789B (zh) * 2011-12-16 2015-11-25 四川科伦药物研究有限公司 一种比阿培南结晶体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008514B1 (en) * 1978-08-25 1982-01-20 Beecham Group Plc Beta-lactam anti-bacterials, compositions containing them and a process for their preparation
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
US4644061A (en) * 1982-09-28 1987-02-17 Bristol-Myers Company Carbapenem antibiotics
CA1273012A (en) * 1984-07-02 1990-08-21 Burton G. Christensen 1-methylcarbapenems having an externally alkylated mono- of bicyclic 2-quarternary heteroarylalkylthio substituent
DE3617626A1 (de) * 1986-05-26 1987-12-03 Bayer Ag Substituierte 6-hydroxymethyl-carbapenem-antibiotika, verfahren zu ihrer herstellung und ihre verwendung
ES2067534T3 (es) * 1988-04-01 1995-04-01 Sankyo Co Derivados de 2-(heterocicliltio)carbapenemo, su preparacion y su aplicacion como antibioticos.

Also Published As

Publication number Publication date
DE3860977D1 (en) 1990-12-13
DK192488D0 (da) 1988-04-08
EP0289801B1 (en) 1990-11-07
FI86729C (fi) 1992-10-12
NO167862B (no) 1991-09-09
EP0289801A1 (en) 1988-11-09
IL85985A0 (en) 1988-09-30
KR960002850B1 (ko) 1996-02-27
KR880012604A (ko) 1988-11-28
GR3001347T3 (en) 1992-08-31
FI881644A (fi) 1988-10-12
DK168015B1 (da) 1994-01-17
FI881644A0 (fi) 1988-04-08
AU1442888A (en) 1988-10-13
ES2019674B3 (es) 1991-07-01
JPH0438756B2 (no) 1992-06-25
FI86729B (fi) 1992-06-30
JPS6425779A (en) 1989-01-27
DK192488A (da) 1988-10-12
AU613356B2 (en) 1991-08-01
CA1340274C (en) 1998-12-15
NO881534L (no) 1988-10-12
IL85985A (en) 1993-07-08
NO881534D0 (no) 1988-04-08

Similar Documents

Publication Publication Date Title
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO167862C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt(1r, 5s, 6s)-2-substituert tio-6-((r)-1-hydroksyetyl)-1-metyl-carbapenem-3-karboksylsyrederivat.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO163857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO165916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO172495C (no) Fremgangsmaate for fremstilling av terapeutisk aktive, ikke-mettede aminosyreforbindelser
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO881884L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO167573C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r, 6s,)-6-((r)-1-hydroksyetyl)-2-azacykloalkyltio-2-penem-3-karboksyl-syrederivater.
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO166322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO165399C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r,6s)-6-((r)-1-hydroksyetyl)-penem-derivater.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees